Computational repurposing of FDA-approved drugs as candidate PPARδ ligands with potential relevance to hepatic fibrosis

Computational Biology and Chemistry · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles